Product Name: 2,3-Dihydrobenzofuranyl-5-acetic acid CAS NO:69999-16-2
Chemical & Physical Properties:
Appearance : white to light yellow crystal powder
Boiling Point:345.8℃ at 760 mmHg
Melting Point: 105-107℃
2,3-Dihydrobenzo[b]furan-5-acetic acid is used to Darifenacin Intermediate;
Darifenacin was developed by Novartis. It was first launched in Germany in January 2005 and launched in the United States in February, under the trade name: Emselex/Enablex. It is a competitive muscarinic M3 receptor antagonist, used for the treatment of urgency. Overactive bladder (OAB) patients with symptoms of urinary incontinence, urgency, and frequent urination.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.